Your browser doesn't support javascript.
loading
In vivo testing of mucus-permeating nanoparticles for oral insulin delivery using Caenorhabditis elegans as a model under hyperglycemic conditions.
Martínez-López, Ana L; González-Navarro, Carlos J; Aranaz, Paula; Vizmanos, José L; Irache, Juan M.
Affiliation
  • Martínez-López AL; NANO-VAC Research Group, Department of Chemistry and Pharmaceutical Technology, School of Pharmacy and Nutrition, University of Navarra, Pamplona 31080, Spain.
  • González-Navarro CJ; Center for Nutrition Research, School of Pharmacy and Nutrition, University of Navarra, Pamplona 31080, Spain.
  • Aranaz P; Center for Nutrition Research, School of Pharmacy and Nutrition, University of Navarra, Pamplona 31080, Spain.
  • Vizmanos JL; Department of Biochemistry & Genetics, School of Science, University of Navarra, Pamplona 31080, Spain.
  • Irache JM; Navarra Institute for Health Research (IdiSNA), Pamplona 31080, Spain.
Acta Pharm Sin B ; 11(4): 989-1002, 2021 Apr.
Article in En | MEDLINE | ID: mdl-33996411

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Acta Pharm Sin B Year: 2021 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Acta Pharm Sin B Year: 2021 Document type: Article Affiliation country: